Peptide gastrointestinal

Pancreatic polypeptide (PP) Peptide Gastrointestinal tract Increased gut motility and gastric... 

Motilin Peptide Gastrointestinal tract Stimulation of gastrointestinal... 

GIF Peptide Gastrointestinal tract Inhibition of gastric secretion and... 

Substance P (SP) Peptide Gastrointestinal tract Sensory neurotransmitter,... 

The principal hormones of the human posterior pituitary include the two nonapeptides, oxytocin [50-56-6] and arginine vasopressin [11000-17-2] (antidiuretic hormone, ADH). Many other hormones, including opioid peptides (see Opioids, endogenous), cholecystokinin [9011-97-6] (CCK) (see Hormones, BRAIN oligopeptides), and gastrointestinal peptides, also have been located in mammalian neurohypophysis (6), but are usually found in much lower concentrations (7). Studies have demonstrated that oxytocin and vasopressin are synthesized in other human organs, both centrally and peripherally, and there is considerable evidence for their role as neurotransmitters (see Neuroregulators) (8). 

The gastrointestinal hormone secretin is prepared by fragment condensation. The tetrapeptide L-Thr-L-Phe-L-Thr-L Ser is coupled to the C-terminal nonadecapeptide of the hormone, and the tetrapeptide L-His-L-Ser- 3-benzyl-L-Asp-Gly is coupled to the tricosa-peptide resulting from the first coupling. 

Incretin Hormones. Figure 3 Processing of the proglucagon. The proglucagon peptide is synthesized in pancreatic cells and cells from the gastrointestinal (Gl) tract and the brain. Different proconvertases process the peptide so that in the pancreas the glucagon is produced whereas in the Gl tract and the brain, the GLP-1 and GLP-2 peptides are mainly released. 

As to be expected from a peptide that has been highly conserved during evolution, NPY has many effects, e.g. in the central and peripheral nervous system, in the cardiovascular, metabolic and reproductive system. Central effects include a potent stimulation of food intake and appetite control [2], anxiolytic effects, anti-seizure activity and various forms of neuroendocrine modulation. In the central and peripheral nervous system NPY receptors (mostly Y2 subtype) mediate prejunctional inhibition of neurotransmitter release. In the periphery NPY is a potent direct vasoconstrictor, and it potentiates vasoconstriction by other agents (mostly via Yi receptors) despite reductions of renal blood flow, NPY enhances diuresis and natriuresis. NPY can inhibit pancreatic insulin release and inhibit lipolysis in adipocytes. It also can regulate gut motility and gastrointestinal and renal epithelial secretion. 

Pituitary Adenylyl Cyclase-activating Polypeptide (PACAP) is a 38-amino acid peptide (PACAP-38), which is widely expressed in the central nervous system. PACAP is most abundant in the hypothalamus. It is also found in the gastrointestinal tract, the adrenal gland and in testis. Its central nervous system functions are ill-defined. In the periphery, PACAP has been shown to stimulate catecholamine secretion from the adrenal medulla and to regulate secretion from the pancreas. Three G-protein coupled receptors have been shown to respond to PACAP, PAQ (PACAP type I) specifically binds PACAP, VPACi and VPAC2 also bind vasoactive intestinal peptide (VDP). Activation of PACAP receptors results in a Gs-mediated activation of adenylyl cyclase. 

Delivery of peptides and proteins via the gastrointestinal tract has not been successful because of poor penetration through the intestinal epithelium and high levels of proteolytic activity in the gastrointestinal tract. Liposomal encapsulation of proteins and peptides will not improve the efficiency and capacity of this absorption pathway considerably (e.g., Ryman et al., 1982 Machy and Leserman, 1987 Weiner and Chia-Ming Chiang, 1988). These difficulties in delivery via the oral route caused the parenteral route to remain the preferred route for the administration of therapeutic peptides... 

Casein refers to a family of proteins, namely, ttgi-, 0. 2-, p-, and k-caseins (Table 5.1). Digestion of a- and p-caseins leads to production of peptides that may bind to opioid receptors that exist in the nervous, endocrine, immime, or gastrointestinal system (Kampa et ah, 1996 Meisel, 2004). These compoimds may modulate absorption processes in the gut and can potentially affect gastrointestinal fimction through transit... 

Hypoperfusion of skeletal muscles leads to fatigue, weakness, and exercise intolerance. Decreased perfusion of the central nervous system (CNS) is related to confusion, hallucinations, insomnia, and lethargy. Peripheral vasoconstriction due to SNS activity causes pallor, cool extremities, and cyanosis of the digits. Tachycardia is also common in these patients and may reflect increased SNS activity. Patients will often exhibit polyuria and nocturia. Polyuria is a result of increased release of natriuretic peptides caused by volume overload. Nocturia occurs due to increased renal perfusion as a consequence of reduced SNS renal vasoconstrictive effects at night. In chronic severe HF, unintentional weight loss can occur which leads to a syndrome of cardiac cachexia. This results from several factors, including loss of appetite, malabsorption due to gastrointestinal edema, elevated metabolic rate, and elevated levels of proinflammatory cytokines. 

WA Ritschel. Microemulsions for improved peptide absorption from the gastrointestinal tract. Methods Find Exp Clin Pharmacol 13 205-220, 1991. 

Herrera-Ruiz, D., et al. Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues. AAPS PharmSci. 2001, 3, E9. 

Pan, Y., et al. Expression of a cloned ovine gastrointestinal peptide transporter (oPepTl) in Xenopus oocytes induces uptake of oligopeptides in vitro. J. Nutr. 2001, 131, 1264-1270. 

Many neuropeptides were originally identified as pituitary or gastrointestinal hormones 317 Peptides can be grouped by structural and functional similarity 317 The function of peptides as first messengers is evolutionarily very old 318 Various techniques are used to identify additional neuropeptides 319 The neuropeptides exhibit a few key differences from the classical neurotransmitters 319... 

---